NCT01612455

Brief Summary

The purpose of this study is to implement and assess a behavioral and structural intervention in Russia designed to support and motivate HIV-infected narcology heroin dependent patients (i.e., IDUs) to engage (i.e., initiate and retain) in HIV medical care and ultimately improve their HIV outcomes. The central hypothesis is that an intervention that involves coordination between the narcology and HIV systems via HIV case management delivered by a peer to help motivate and reduce barriers to HIV care will lead to engagement in HIV care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
349

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 1, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 5, 2012

Completed
26 days until next milestone

Study Start

First participant enrolled

July 1, 2012

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2016

Completed
Last Updated

June 21, 2018

Status Verified

June 1, 2018

Enrollment Period

3.5 years

First QC Date

June 1, 2012

Last Update Submit

June 20, 2018

Conditions

Keywords

HIVdrug addictionRussiacase management

Outcome Measures

Primary Outcomes (5)

  • 1) initiation of HIV care

    Greater than or equal to 1 visit to HIV medical care within 6 months of enrollment

    6 months

  • 2) retention in HIV care

    Greater than or equal 1 visit to medical care in 2 consecutive 6 month periods within 12 months

    12 months

  • 3) appropriate HIV care

    prescribed ART if CD4 cell count is less than 350 or having a second CD4 count if CD4 is greater than or equal to 350 within 12 months (Note: As guidelines change over time, this outcome may be updated accordingly.)

    12 months

  • 4) improved HIV health outcomes

    CD4 cell count at 12 months (compared to CD4 cell count at baseline)

    12 months

  • 5) Establish the contextual factors that influence adoption and sustainability of the LINC intervention in Russia

    Qualitative implementation science analysis, including pre-implementation focus groups, interviews, and surveys in Russia; post-implementation qualitative interviews in Russia.

    4 years

Study Arms (2)

Standard of Care

NO INTERVENTION

Control participants will receive the narcology hospital's standard of care. With regard to linkage to HIV medical care, patients will be given printed information about where to obtain HIV medical care - the outpatient clinic that is involved in the intervention. Control patients will be referred to outpatient narcology care as part of standard of care. If control participants are newly diagnosed with HIV infection at the addiction hospital, they will receive HIV post test counseling consistent with CDC recommendations (this represents an enhancement of the current standard of care in Russia).

LINC Case Management (Intervention)

EXPERIMENTAL

LINC Case Management (study Intervention) - see Intervention description

Behavioral: LINC Case Management

Interventions

The 1st case management (CM) session will be at the Narcology Hospital and will follow a modified strengths-based case management curriculum. As part of this first session, the CM will show a 10 minute video clip produced by a Russian NGO of HIV-infected patients talking about accessing HIV care. The CM will also tell the patient what his/her CD4 cell count is and discuss what it means with the patient. The case manager will help the client identify the outpatient HIV clinic on a map and will discuss basic drug harm reduction ideas with the client. The remaining 4 CM sessions will happen over the following 6 months. Sessions may happen at the HIV clinic, NGOs, or in the community. The HIV CM helps the client understand the importance of HIV care, identify barriers to care acquisition and recognize one's own strengths, abilities and assets to reduce self-identified barriers to care. The HIV CM's primary aim is to have the client attend an appointment at the HIV outpatient clinic.

LINC Case Management (Intervention)

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 18 - 70 years
  • HIV-infected
  • hospitalized at a narcology hospital
  • history of injection drug use
  • available for CD4 testing
  • has 2 contacts to assist with follow-up
  • lives within 100 km of St. Petersburg, Russia
  • has telephone
  • willing to receive care at Botkin Infectious Disease Hospital

You may not qualify if:

  • currently on ART
  • not fluent in Russian
  • cognitive impairment precluding informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Botkin Infectious Disease Hospital

Saint Petersburg, Russia

Location

City Addiction Hospital

Saint Petersburg, Russia

Location

Pavlov State Medical University

Saint Petersburg, Russia

Location

Related Publications (1)

  • Gnatienko N, Han SC, Krupitsky E, Blokhina E, Bridden C, Chaisson CE, Cheng DM, Walley AY, Raj A, Samet JH. Linking Infectious and Narcology Care (LINC) in Russia: design, intervention and implementation protocol. Addict Sci Clin Pract. 2016 May 4;11(1):10. doi: 10.1186/s13722-016-0058-5.

MeSH Terms

Conditions

HIV InfectionsSubstance-Related Disorders

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesChemically-Induced DisordersMental Disorders

Study Officials

  • Jeffrey Samet, MD, MA, MPH

    Boston Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief, Section of General Internal Medicine

Study Record Dates

First Submitted

June 1, 2012

First Posted

June 5, 2012

Study Start

July 1, 2012

Primary Completion

January 1, 2016

Study Completion

January 1, 2016

Last Updated

June 21, 2018

Record last verified: 2018-06

Locations